Smoking Prevention and Cessation Policies

  • Christina Gratziou
  • Charis Roussos

Keywords

Chronic Obstructive Pulmonary Disease Smoking Cessation Nicotine Dependence Nicotine Replacement Therapy Tobacco Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    European Commission. European Opinion Research Group. Smoking and the environment: actions and attitudes. Special Euro barometer 183/Wave 58.2, 2003; 1. http://europa.eu.int./comm/public_pinion/Google Scholar
  2. 2.
    World Bank. Curbing the epidemic: governments and the economics of tobacco control. Washington DC, 1999. www1.WorldBank.org/tobacco/chapter1.aspGoogle Scholar
  3. 3.
    Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R. Mortality from smoking worldwide. Br Med Bull 1996; 52:12.PubMedGoogle Scholar
  4. 4.
    European Respiratory Society (ERS). The burden of lung disease. In: Loddenkemper R, Gibson GJ, Sibille Y (eds) European Lung White Book: The First Comprehensive Survey on Respiratory Health in Europe. Sheffield, UK: ERSJ, 2003:7.Google Scholar
  5. 5.
    European Respiratory Society (ERS). Lung cancer. In: Loddenkemper R, Gibson GJ, Sibille Y (eds) European Lung White Book: The First Comprehensive Survey on Respiratory Health in Europe. Sheffield, UK: ERSJ, 2003:44.Google Scholar
  6. 6.
    World Health Organization (WHO). Guidelines for Con trolling and Monitoring the Tobacco Epidemic. Prepublication draft. Geneva: WHO, 1995.Google Scholar
  7. 7.
    Europe against cancer programme. Official Journal 26/2/1987; C:50:58.Google Scholar
  8. 8.
    European Commission. Tobacco or health in the European Union: the ASPECT Consortium. October 2004 http://europa.eu.intGoogle Scholar
  9. CDC. Reasons for tobacco use and symptoms of nicotine withdrawal among adolescent and young adult tobacco users. Morbidity and Mortality Weekly Report 1994; 43:745.Google Scholar
  10. 10.
    IASLC Workshop. Prevention and early detection of lung cancer. Clinical aspects proceedings. Elsinore, Denmark, 1996.Google Scholar
  11. 11.
    Lightwood JM, Glantz SA. Short term economic and health benefits of smoking cessation. Circulation 1997; 96:1089.PubMedGoogle Scholar
  12. 12.
    Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years observation on male British doctors. BMJ 2004; 328:1519.PubMedCrossRefGoogle Scholar
  13. 13.
    Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild to moderate chronic obstructive pulmonary disease: the Lung Health Study. Am J Res Crit Care Med 2000; 161:381.Google Scholar
  14. 14.
    Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321:323.PubMedCrossRefGoogle Scholar
  15. 15.
    World Health Organization (WHO). Tobacco or health: a global status report. Geneva: WHO, 1997.Google Scholar
  16. 16.
    Zhu SH, Melcer T, Sun J, et al. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000; 18:305.PubMedCrossRefGoogle Scholar
  17. 17.
    Royal College of Physicians. Nicotine addiction in Britain. London: Royal College of Physicians, 2000.Google Scholar
  18. 18.
    Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Health Psychol 1992; 11:331.PubMedCrossRefGoogle Scholar
  19. 19.
    Fagerstrom K-O, Schneider N. Measuring nicotine dependence: a review of the Fagerström tolerance questionnaire. J Behav Med 1989; 12:159.PubMedCrossRefGoogle Scholar
  20. 20.
    American College of Chest Physicians, American Thoracic Society, Asia Pacific Society of Respiratory, Canadian Thoracic Society, European Respiratory Society, International Union Against Tuberculosis and Lung Diseases Smoking and Health. A physician’s responsibility: a statement of the joint committee on smoking and health. Eur Respir J 1995; 8:1808.CrossRefGoogle Scholar
  21. 21.
    USDHHS Tobacco and the Clinician Interventions for Medical and Dental Practice, NCL 94-3693. US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1994.Google Scholar
  22. 22.
    Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation. Clinical practice guideline no. 18, AHCPR 96-0692. US Department of Health and Human Services, Public Health Service, Agency for Health Service, Agency for Health Care Policy and Research. The smoking cessation clinical practice guideline. Panel and staff. The Agency for Health Care Policy and Research. JAMA 1996; 275:1270.CrossRefGoogle Scholar
  23. 23.
    Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: quick reference guide for clinicians. Rockville, MD: US Department of Health and Human Ser vices. Public Health Service, 2000.Google Scholar
  24. 24.
    West R, McNeill A, Ras M. Smoking cessation guidelines for health professionals: an update. Thorax 2000; 55:987.PubMedCrossRefGoogle Scholar
  25. 25.
    World Health Organization (WHO). European partnership to reduce tobacco dependence: WHO evidence-based recommendations on the treatment of tobacco dependence. Geneva: WHO, 2001.Google Scholar
  26. 26.
    National Institute for Clinical Excellence (NICE). Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. National Institute for Clinical Excellence Technology Appraisal Guidance 2002; 39. www.nice.org.ukGoogle Scholar
  27. 27.
    Andersson JE, Joremby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence. Chest 2002; 121:932.CrossRefGoogle Scholar
  28. 28.
    Gratziou CH. The process of stopping smoking. European Respiratory Seminar on Smoking Cessation. European Respiratory Society School. Budapest Dec 2004. www.ersnet.org/eduGoogle Scholar
  29. 29.
    Tonnesen P. Essential communication skills in individual smoking cessation. Review series: patient education. Chronic Respir Dis 2004; 1:221.CrossRefGoogle Scholar
  30. 30.
    Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994; 271:1940.PubMedCrossRefGoogle Scholar
  31. 31.
    Tonnessen P, Paoletti P, Gustavsson G, et al. Higher dos age nicotine patches increase one-year smoking cessation rates: results from the European CEASE-trial. Eur Respir J 1999; 13:238.CrossRefGoogle Scholar
  32. 32.
    West R. Bupropion SR for smoking cessation: expert opinion. Drug Evaluation 2003; 533.Google Scholar
  33. 33.
    Coleman T, West R. Newly available treatments for nicotine addiction: smokers wanting help to stop smoking now have effective treatment options. BMJ 2001; 322:1076.PubMedCrossRefGoogle Scholar
  34. 34.
    Holm KJ, Spencer CM. Bupropion: a review of its use in the management of smoking cessation. Drugs 2000; 59:1007.PubMedCrossRefGoogle Scholar
  35. 35.
    Gratziou C, Francis K, Maragianni A, et al. Bupropion treatment and cognitive behavioral therapy in smoking cessation program. Eur Respir J 2001; 12Google Scholar
  36. 36.
    Balfour DJK. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. Int J Clin Pract 2001; 55:53.PubMedGoogle Scholar
  37. 37.
    Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 2000; 295:321.PubMedGoogle Scholar
  38. 38.
    Hall S, Humeet G, Reus V, et al. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry 2002; 59:930.PubMedCrossRefGoogle Scholar
  39. 39.
    Benowitz NL, Wilson Peng M. Non-nicotine pharmaco-therapy for smoking cessation. Mechanisms and prospects. CNS Drugs 2000; 13:265.CrossRefGoogle Scholar
  40. 40.
    White A, Resch K, Ernst E. A metaanalysis of acupuncture techniques for smoking cessation. Tob Control 1999; 8:393.PubMedCrossRefGoogle Scholar
  41. 41.
    Lancaster T, Stead LF. Individual behavioral counselling for smoking cessation. Cochrane Database Syst Rev 2000; 2:CD001292.PubMedGoogle Scholar
  42. 42.
    British Medical Association. Towards smoke-free public places. London: BMA, 2002.Google Scholar
  43. 43.
    Johnson E, Dominici F, Griswold M, et al. Disease cases and their medical costs attributable to smoking: an analysis of the national medical expenditure survey. J Econometrics 2003; 112:135.CrossRefGoogle Scholar
  44. 44.
    Ruff LK, Volmer T, Nowak D, et al. The economic impact of smoking in Germany. Eur Respir J 2000; 16:385.PubMedCrossRefGoogle Scholar
  45. 45.
    Parrott S, Godfrey C, Raw M, et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax 1998; 53:S1.PubMedCrossRefGoogle Scholar
  46. 46.
    Godfrey C. The economic and social costs of lung cancer and the economics of smoking prevention. Monaldi Arch Chest Dis 2001; 56:458.PubMedGoogle Scholar
  47. 47.
    WHO-World Health Organization. Economic consequences of smoking (ECOS) model. WHO European Partnership Project to Reduce Tobacco Dependence. Copenhagen-Geneva: WHO, 1999. http://www.who.dk/adt/ecos/whoweb.aspGoogle Scholar
  48. 48.
    Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997; 278:1759.##PubMedCrossRefGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2006

Authors and Affiliations

  • Christina Gratziou
    • 1
  • Charis Roussos
    • 2
    • 3
  1. 1.Pulmonary and Critical Care Department Medical SchoolUniversity of Athens Evangelismos HospitalAthensGreece
  2. 2.Evanglismos General HospitalAthens Medical SchoolAthensGreece
  3. 3.Faculty of MedicineMcGill UniversityMontrealCanada

Personalised recommendations